Lite Strategy, Inc. (LITS)
1.11
+0.05
(+4.72%)
USD |
NASDAQ |
Sep 11, 16:00
1.10
-0.01
(-0.90%)
After-Hours: 20:00
Lite Strategy Market Cap : 39.02M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 39.02M |
| September 10, 2026 | 37.27M |
| September 09, 2026 | 37.27M |
| September 08, 2026 | 38.67M |
| September 04, 2026 | 40.08M |
| September 03, 2026 | 36.56M |
| September 02, 2026 | 36.56M |
| September 01, 2026 | 34.95M |
| August 31, 2026 | 34.65M |
| August 28, 2026 | 34.47M |
| August 27, 2026 | 35.16M |
| August 26, 2026 | 34.91M |
| August 25, 2026 | 36.91M |
| August 24, 2026 | 36.21M |
| August 21, 2026 | 34.79M |
| August 20, 2026 | 33.17M |
| August 19, 2026 | 33.05M |
| August 18, 2026 | 31.01M |
| August 17, 2026 | 30.94M |
| August 14, 2026 | 31.17M |
| August 13, 2026 | 31.48M |
| August 12, 2026 | 32.40M |
| August 11, 2026 | 31.68M |
| August 10, 2026 | 30.59M |
| August 07, 2026 | 31.90M |
| Date | Value |
|---|---|
| August 06, 2026 | 32.66M |
| August 05, 2026 | 33.59M |
| August 04, 2026 | 33.20M |
| August 03, 2026 | 34.50M |
| July 31, 2026 | 33.87M |
| July 30, 2026 | 34.71M |
| July 29, 2026 | 33.44M |
| July 28, 2026 | 34.10M |
| July 27, 2026 | 34.33M |
| July 24, 2026 | 34.75M |
| July 23, 2026 | 34.87M |
| July 22, 2026 | 36.21M |
| July 21, 2026 | 35.16M |
| July 20, 2026 | 36.21M |
| July 17, 2026 | 34.68M |
| July 16, 2026 | 34.11M |
| July 15, 2026 | 34.77M |
| July 14, 2026 | 35.05M |
| July 13, 2026 | 33.25M |
| July 10, 2026 | 35.51M |
| July 09, 2026 | 34.91M |
| July 08, 2026 | 34.34M |
| July 07, 2026 | 34.14M |
| July 06, 2026 | 34.30M |
| July 02, 2026 | 33.41M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SELLAS Life Sciences Group, Inc. | 2.331B |
| ACADIA Pharmaceuticals, Inc. | 4.790B |
| Alnylam Pharmaceuticals, Inc. | 33.26B |
| Anika Therapeutics, Inc. | 279.17M |
| Savara, Inc. | 1.089B |
Market Cap Related Metrics
| Price to Book Value | 0.6866 |
| Price | 1.11 |
| Earnings Yield | -181.5% |